Needham Initiates Medtronic At Buy
Analysts at Needham initiated coverage on shares of Medtronic (NYSE: MDT) with a Buy rating.
The target price for Medtronic is set to $74.
Medtronic shares have climbed 16.85% over the past 52 weeks, while the S&P 500 index has jumped 16.68% in the same period.
Medtronic's shares fell 1.26% to close at $62.54 yesterday.
Latest Ratings for MDT
|Jan 2017||Morgan Stanley||Downgrades||Overweight||Equal-Weight|
|Jan 2017||JP Morgan||Downgrades||Overweight||Neutral|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.